EB
Enveric Biosciences, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$5Msold at filing
Total offering$5M
Investors in the raise4count reported to the SEC
FiledMay 4, 2026first sale Apr 17, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Kevin M. CoveneyExecutive Officer
Michael W. SchabackerDirector
George W. KeglerDirector
Sheila W. DeWittDirector
Joseph E. TuckerExecutive Officer, Director
Frank W. PasqualoneDirector
Michael D. WebbDirector
Executive officers, directors and promoters as listed on the Form D.